IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$6.99
-0.40 (-5.41%)
As of Nov 21, 10:53 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +253.2% upside
Low Target $14.59
Average Target $24.69
High Target $25.91
Current Price $6.99
Current
$6.99
Target
$24.69
$14.59 $24.69 avg $25.91
Scenario Analysis
Bear Case
$14.59
108.7%
Low target
Base Case
$24.69
+253.2%
Avg target
Bull Case
$25.91
+270.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$17.43
-59.9% from high
52-Week Low
$5.06
+38.1% from low
Target vs 52W High
$24.69
+41.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -10.0%
AMGN
Amgen Inc
Hold 42 43% $190.87 -56.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +117.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.7%
MRNA
Moderna Inc
Hold 31 32% $149.45 -23.4%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -47.7%
BIIB
Biogen Inc
Buy 44 73% $91.45 -63.4%